Fondaparinux and acute coronary syndromes: update on the OASIS 5–6 studies
François SchieleDepartment of Cardiology, University Hospital Jean-Minjoz, Besançon, FranceAbstract: Anticoagulant therapy is a major component in the management of acute coronary syndromes (ACS). Four anticoagulant agents are currently commercially available for ACS, n...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2010-03-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | http://www.dovepress.com/fondaparinux-and-acute-coronary-syndromes-update-on-the-oasis-5ndash6--a4142 |